A single-center, prospective, randomized controlled trial of tislelizumab combined with platinum-containing chemotherapy as first-line treatment for HIV-positive patients with advanced non-small cell lung cancer.

Authors: Yaping Quan, Hao Li, Xianhuai Jin, Yan Zeng, Jie Shen, Yongwei Duan, Nan Lin, Yong Hu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20590

Source: Full article

e20590